Please use symbol entry at top right of page to search

Transplant Drug Monitoring Assay Market is Predicted to Expand at a CAGR of 11.0% during the Forecast Period, Notes TMR Study

  • Tacrolimus, which was recently approved by the FDA as a transplantation medicine, is anticipated to boost the category in the years to come
  • The Asia Pacific region is a major region for transplant drug monitoring assay. The growing emphasis on organ donation is what is driving the market in Asia Pacific

 ALBANY, N.Y., June 28, 2022 /PRNewswire/ -- The value of the global transplant drug monitoring assay market stood at US$ 198.0 Mn in 2021. The global market is anticipated to rise at CAGR of 11.0% during the forecast period, from 2022 to 2031. The global transplant drug monitoring assay market is also expected to attain valuation surpassing US$ 542 Mn by 2031. In order to keep blood and plasma concentrations of immunosuppressants within the acceptable therapeutic limits, healthcare providers must use therapeutic drug monitoring (TDM) in transplant medicine. TDM controls concentrations to ensure that they are neither too high or too low, reducing the likelihood of toxicity or rejection, as appropriate. These factors are likely to drive market demand for transplant drug monitoring assay in the years to come.

TMR Logo

In order to assist in patient monitoring, top firms in the healthcare sector provide a wide range of immunosuppressant drug monitoring (ISD) tests, including those for everolimus, cyclosporine, tacrolimus, and mycophenolic acid. In the coming years, firms in the transplant drug monitoring assay market is likely to benefit financially from rising healthcare spending, government reimbursement schemes, improved healthcare infrastructure, and rising global per capita income.

The global market for transplant drug monitoring assay is anticipated to expand significantly during the forecasted period. The need for organ transplants is growing, R&D spending is surging, and chronic liver and kidney disorders are becoming more common, all of which contribute to this market expansion. For companies in the global transplant drug monitoring assay market, the rising demand for home-based therapeutic drug monitoring and point-of-care therapeutic drug monitoring is projected to present profitable prospects.

Request Brochure of Transplant Drug Monitoring Assay Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=84851

Key Findings of Market Report

  • The global population is aging quickly, particularly in affluent nations like Japan, Germany, and the US. The need for organ transplants as well as replacements is being driven by an increase in the prevalence of chronic illnesses of the pancreas, kidney, heart, and liver, as well as blood disorders like aplastic anemia and leukemia. The market for transplant medication monitoring assays is anticipated to grow as a result.
  • As a result of government organizations' activities, more people are becoming organ donors worldwide. Through educational initiatives, financial support, and practical programs and policies, several governmental entities in developing and developed nations promote organ donation. The global transplant drug monitoring assay market expansion is also attributed to government encouragement for organ donation.
  • Depending on product type, the equipment segment accounted for a sizable portion of the global market in 2021. The category is one of the key market segments in transplant drug monitoring assay and is anticipated to expand quickly throughout the projection period. Mid-to-high volume laboratories can adapt their operations to increase productivity and cut costs with the help of immunoassay analyzers and clinical chemistry analyzers. This equipment offers laboratories all around the world dependability and effectiveness that has been field-tested, and it has great onboard parameters throughput.

Request for Analysis of COVID-19 Impact on Transplant Drug Monitoring Assay Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=84851

Global Transplant Drug Monitoring Assay Market: Growth Drivers

  • In terms of technology, the chromatography-MS category is likely to expand rapidly in the years to come and is expected to have prominent market share for transplant drug monitoring assay.  The category is anticipated to grow at a CAGR of 12.2% during the forecast timeframe. The segment's expansion can be attributed to the global increase in demand for organ transplants.
  • In 2021, North America held a significant percentage of the global transplant drug monitoring assay market and is likely to offer largest opportunity for transplant drug monitoring assay. The supremacy of North America can be attributed to surgical methods, advancements in medical science, organ transplant success rates, and immunosuppressive medications.

Get Exclusive PDF Sample Copy of Transplant Drug Monitoring Assay Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84851

Global Transplant Drug Monitoring Assay Market: Key Players

Some of the key market players are

  • Hoffmann-La Roche Ltd.
  • H.U. Group Holdings, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers AG
  • Abbott Laboratories

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84851

Global Transplant Drug Monitoring Assay Market: Segmentation

Product

  • Equipment
  • Consumables

Technology

  • Chromatography-MS
  • Immunoassays

Drug

  • Tacrolimus
  • Methotrexate
  • Cyclosporin
  • Others

End-Use

  • Hospital Laboratories
  • Commercial & Private Laboratories
  • Others

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Organ Transplant Rejection Medications Market: The global organ transplant rejection medications market is expected to reach a value of ~US$ 6.3 Bn by the end of the forecast period. High prevalence and increase in incidence of several acute and chronic disorders worldwide are anticipated to drive the global organ transplant rejection medications market.

Multiplex Detection Immunoassays Market: The global multiplex detection immunoassays market is on the course to surpass US$ 3.65 Bn mark by the end of 2030. High prevalence and increase in incidence rate of chronic and infectious diseases are projected to drive the global multiplex detection immunoassays market in the near future.

Immunoassay Market: Rise in prevalence of such diseases is likely to provide lucrative opportunities for the prominent market players. In order to speed-up the diagnosis process, the companies operating in the global immunoassay market are focusing on development of novel immunoassay products.

Clinical Chemistry Analyzers Market: The global clinical chemistry analyzers market was valued at ~US$ 11.3 Bn in 2018. The clinical chemistry analyzers market is projected to expand at a CAGR of ~4% from 2019 to 2027.

Prepacked Chromatography Columns Market: Technology has been the biggest aid for development in healthcare. As new diagnostic and treatment methods come up, the pharmaceutical industry becomes stronger. This has a positive impact on the markets that support smooth operations of pharmaceutical companies. One such aiding market for pharmaceuticals is the prepacked chromatography columns market.

Cleanroom Consumables Market: The high demand for products such as goggles, gloves, surgical masks, and gowns are translating into income streams for stakeholders in the global cleanroom consumables market. The ever-evolving nature of coronavirus strains has kept medical professionals engaged in innovations for antiviral drugs and vaccines.

PRP and PRF in Cosmetics Market: Changing lifestyles of the people in developing regions, increase in per capita income, and rise in awareness about beautification contribute to the growth of the global PRP and PRF in cosmetics market.

Fetal Bovine Serum Market: Technological advancement in biopharmaceuticals, innovative drug development process, and rising applications in cost-effective personalized medicine are some of the major factors driving the demand for biologics.

About Transparency Market Research

Transparency Market Research is a global market research company providing business custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact Us:
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: http://www.transparencymarketresearch.com  
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/transplant-drug-monitoring-assay-market-is-predicted-to-expand-at-a-cagr-of-11-0-during-the-forecast-period-notes-tmr-study-301576391.html

SOURCE Transparency Market Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.